Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Extensive transmission of microbes along the gastrointestinal tract.

Schmidt TSB, Hayward MR, Coelho LP, Li SS, Costea PI, Voigt AY, Wirbel J, Maistrenko OM, Alves RJ, Bergsten E, de Beaufort C, Sobhani I, Heintz-Buschart A, Sunagawa S, Zeller G, Wilmes P, Bork P.

Elife. 2019 Feb 12;8. pii: e42693. doi: 10.7554/eLife.42693. [Epub ahead of print]

2.

Robotic Versus Laparoscopic Colorectal Cancer Surgery in Elderly Patients: A Propensity Score Match Analysis.

de'Angelis N, Abdalla S, Bianchi G, Memeo R, Charpy C, Petrucciani N, Sobhani I, Brunetti F.

J Laparoendosc Adv Surg Tech A. 2018 Nov;28(11):1334-1345. doi: 10.1089/lap.2018.0115. Epub 2018 May 31.

PMID:
29851362
3.

[Radiation therapy in patients with inflammatory bowel disease. A review].

Jmour O, Pellat A, Colson-Durand L, To NH, Latorzeff I, Sargos P, Sobhani I, Belkacemi Y.

Bull Cancer. 2018 May;105(5):517-522. doi: 10.1016/j.bulcan.2018.02.005. Epub 2018 Apr 10. Review. French.

PMID:
29653817
4.

Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.

Dinh A, Fessi H, Duran C, Batista R, Michelon H, Bouchand F, Lepeule R, Vittecoq D, Escaut L, Sobhani I, Lawrence C, Chast F, Ronco P, Davido B.

J Hosp Infect. 2018 Aug;99(4):481-486. doi: 10.1016/j.jhin.2018.02.018. Epub 2018 Mar 2.

PMID:
29477634
5.

2017 WSES guidelines for the management of iatrogenic colonoscopy perforation.

de'Angelis N, Di Saverio S, Chiara O, Sartelli M, Martínez-Pérez A, Patrizi F, Weber DG, Ansaloni L, Biffl W, Ben-Ishay O, Bala M, Brunetti F, Gaiani F, Abdalla S, Amiot A, Bahouth H, Bianchi G, Casanova D, Coccolini F, Coimbra R, de'Angelis GL, De Simone B, Fraga GP, Genova P, Ivatury R, Kashuk JL, Kirkpatrick AW, Le Baleur Y, Machado F, Machain GM, Maier RV, Chichom-Mefire A, Memeo R, Mesquita C, Salamea Molina JC, Mutignani M, Manzano-Núñez R, Ordoñez C, Peitzman AB, Pereira BM, Picetti E, Pisano M, Puyana JC, Rizoli S, Siddiqui M, Sobhani I, Ten Broek RP, Zorcolo L, Carra MC, Kluger Y, Catena F.

World J Emerg Surg. 2018 Jan 24;13:5. doi: 10.1186/s13017-018-0162-9. eCollection 2018. Review.

6.

Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.

Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, Ducreux M, Gornet JM, Goujon G, Aparicio T, Taieb J, Bachet JB, Hemery F, Retbi A, Mons M, Flicoteaux R, Rhein B, Baron S, Cherrak I, Rufat P, Le Corvoisier P, de'Angelis N, Natella PA, Maoulida H, Tournigand C, Durand Zaleski I, Bastuji-Garin S.

Ann Oncol. 2018 Apr 1;29(4):931-937. doi: 10.1093/annonc/mdy031.

7.

Patients' comorbidities reduce the clinical value of emergency colonoscopy: results of a retrospective cohort study.

Cremone C, Esch A, Gagniere C, Fugazza A, Mesli F, Levy M, Amiot A, Laurent A, LeBaleur Y, Hemery F, De'Angelis N, Brunetti F, Sobhani I.

Endosc Int Open. 2017 Nov;5(11):E1119-E1127. doi: 10.1055/s-0043-118001. Epub 2017 Nov 8.

8.

Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.

Rentien AL, Lévy M, Copie-Bergman C, Gagniere C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Delchier JC, Amiot A.

Dig Liver Dis. 2018 Feb;50(2):181-188. doi: 10.1016/j.dld.2017.10.014. Epub 2017 Oct 27.

PMID:
29102522
9.

Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents: a systematic review and meta-analysis.

Landi F, de'Angelis N, Sepulveda A, Martínez-Pérez A, Sobhani I, Laurent A, Soubrane O.

Transpl Int. 2018 Feb;31(2):131-151. doi: 10.1111/tri.13089. Epub 2017 Nov 16. Review.

10.

Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?

Davido B, Batista R, Michelon H, Lepainteur M, Bouchand F, Lepeule R, Salomon J, Vittecoq D, Duran C, Escaut L, Sobhani I, Paul M, Lawrence C, Perronne C, Chast F, Dinh A.

J Hosp Infect. 2017 Apr;95(4):433-437. doi: 10.1016/j.jhin.2017.02.001. Epub 2017 Feb 6.

PMID:
28237504
11.

Laparoscopic vs. open surgery for the treatment of iatrogenic colonoscopic perforations: a systematic review and meta-analysis.

Martínez-Pérez A, de'Angelis N, Brunetti F, Le Baleur Y, Payá-Llorente C, Memeo R, Gaiani F, Manfredi M, Gavriilidis P, Nervi G, Coccolini F, Amiot A, Sobhani I, Catena F, de'Angelis GL.

World J Emerg Surg. 2017 Feb 6;12:8. doi: 10.1186/s13017-017-0121-x. eCollection 2017. Review.

12.

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.

Amiot A, Jooste V, Gagniere C, Lévy M, Copie-Bergman C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Bouvier AM, Delchier JC.

Leuk Lymphoma. 2017 Sep;58(9):1-11. doi: 10.1080/10428194.2017.1283033. Epub 2017 Jan 31.

PMID:
28140708
13.

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouché O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepère C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL; FFCD 2001-02 investigators.

Eur J Cancer. 2017 Mar;74:98-108. doi: 10.1016/j.ejca.2016.09.029. Epub 2016 Nov 5.

PMID:
27825697
14.

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker.

Garrigou S, Perkins G, Garlan F, Normand C, Didelot A, Le Corre D, Peyvandi S, Mulot C, Niarra R, Aucouturier P, Chatellier G, Nizard P, Perez-Toralla K, Zonta E, Charpy C, Pujals A, Barau C, Bouché O, Emile JF, Pezet D, Bibeau F, Hutchison JB, Link DR, Zaanan A, Laurent-Puig P, Sobhani I, Taly V.

Clin Chem. 2016 Aug;62(8):1129-39. doi: 10.1373/clinchem.2015.253609. Epub 2016 Jun 1.

15.

Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge.

Fischer N, Sechet E, Friedman R, Amiot A, Sobhani I, Nigro G, Sansonetti PJ, Sperandio B.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2993-3001. doi: 10.1073/pnas.1605997113. Epub 2016 May 9.

16.

Confocal Laser Endomicroscopy in Gastrointestinal and Pancreatobiliary Diseases: A Systematic Review and Meta-Analysis.

Fugazza A, Gaiani F, Carra MC, Brunetti F, Lévy M, Sobhani I, Azoulay D, Catena F, de'Angelis GL, de'Angelis N.

Biomed Res Int. 2016;2016:4638683. doi: 10.1155/2016/4638683. Epub 2016 Feb 17. Review.

17.

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).

Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal J, Breysacher G, Legoux JL, Lepère C, Charneau J, Cretin J, Chone L, Azzedine A, Bouché O, Sobhani I, Bedenne L, Mitry E; FFCD investigators.

Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20.

PMID:
26487578
18.

Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Moossavi S, Bishehsari F, Ansari R, Vahedi H, Nasseri-Moghaddam S, Merat S, Sobhani I, Keshavarzian A, Malekzadeh R.

Middle East J Dig Dis. 2015 Jul;7:177-80. No abstract available.

19.

(1)H NMR Spectroscopy of Fecal Extracts Enables Detection of Advanced Colorectal Neoplasia.

Amiot A, Dona AC, Wijeyesekera A, Tournigand C, Baumgaertner I, Lebaleur Y, Sobhani I, Holmes E.

J Proteome Res. 2015 Sep 4;14(9):3871-81. doi: 10.1021/acs.jproteome.5b00277. Epub 2015 Aug 7.

PMID:
26211820
20.

Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial.

Karoui M, Rullier A, Luciani A, Bonnetain F, Auriault ML, Sarran A, Monges G, Trillaud H, Le Malicot K, Leroy K, Sobhani I, Bardier A, Moreau M, Brindel I, Seitz JF, Taieb J.

BMC Cancer. 2015 Jul 10;15:511. doi: 10.1186/s12885-015-1507-3.

21.

Potential of fecal microbiota for early-stage detection of colorectal cancer.

Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P.

Mol Syst Biol. 2014 Nov 28;10:766. doi: 10.15252/msb.20145645.

22.

The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.

Amiot A, Mansour H, Baumgaertner I, Delchier JC, Tournigand C, Furet JP, Carrau JP, Canoui-Poitrine F, Sobhani I; CRC group of Val De Marne.

PLoS One. 2014 Jul 15;9(7):e99233. doi: 10.1371/journal.pone.0099233. eCollection 2014.

23.

Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.

Amiot A, Lévy M, Copie-Bergman C, Dupuis J, Szablewski V, Le Baleur Y, Baia M, Belhadj K, Sobhani I, Leroy K, Haioun C, Delchier JC.

Aliment Pharmacol Ther. 2014 Mar;39(6):619-28. doi: 10.1111/apt.12635. Epub 2014 Jan 27.

24.

Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308.

Michel P, Breysacher G, Mornex F, Seitz JF, Pere-Verge D, Martel-Lafay I, Faroux R, Chapet S, Sobhani I, Pezet D, Aparicio T, Nguyen S, Dousset B, Jouve JL, Maillard E.

Eur J Cancer. 2014 Apr;50(6):1076-83. doi: 10.1016/j.ejca.2013.12.009. Epub 2014 Jan 13.

PMID:
24433843
25.

Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.

Roperch JP, Incitti R, Forbin S, Bard F, Mansour H, Mesli F, Baumgaertner I, Brunetti F, Sobhani I.

BMC Cancer. 2013 Dec 1;13:566. doi: 10.1186/1471-2407-13-566.

26.

Functional digestive symptoms and quality of life in patients with Ehlers-Danlos syndromes: results of a national cohort study on 134 patients.

Zeitoun JD, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C.

PLoS One. 2013 Nov 22;8(11):e80321. doi: 10.1371/journal.pone.0080321. eCollection 2013.

27.

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, Mitry E, Taieb J, Di Fiore F, Gornet JM, Thirot-Bidault A, Sobhani I, Malka D, Lecomte T, Locher C, Bonnetain F, Laurent-Puig P.

Br J Cancer. 2013 Dec 10;109(12):3057-66. doi: 10.1038/bjc.2013.677. Epub 2013 Nov 5.

28.

Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?

Chiaradia M, Baranes L, Van Nhieu JT, Vignaud A, Laurent A, Decaens T, Charles-Nelson A, Brugières P, Katsahian S, Djabbari M, Deux JF, Sobhani I, Karoui M, Rahmouni A, Luciani A.

J Magn Reson Imaging. 2014 Feb;39(2):317-25. doi: 10.1002/jmri.24172. Epub 2013 May 30.

PMID:
23723012
29.

Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?

Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC.

Therap Adv Gastroenterol. 2013 May;6(3):215-29. doi: 10.1177/1756283X12473674.

30.

Infliximab infusion time in patients with inflammatory bowel diseases: is longer really safer?

Belhassan M, Zeitoun JD, Lefevre JH, Charachon A, Amiot A, Le Baleur Y, Sobhani I, Delchier JC.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):189-92. doi: 10.1016/j.clinre.2012.07.004. Epub 2012 Dec 12.

PMID:
23246140
31.

Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.

Lévy M, Copie-Bergman C, Amiot A, Dupuis J, Le Baleur Y, Belhadj K, Hémery F, Sobhani I, Delfau-Larue MH, Leroy K, Haioun C, Delchier JC.

Leuk Lymphoma. 2013 May;54(5):940-4. doi: 10.3109/10428194.2012.729832. Epub 2012 Oct 4.

PMID:
22978684
32.

Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain.

Coïc YM, Baleux F, Poyraz Ö, Thibeaux R, Labruyere E, Chretien F, Sobhani I, Lazure T, Wyplosz B, Schneider G, Mulard L, Sansonetti PJ, Marteyn BS.

J Biol Chem. 2012 May 4;287(19):15916-22. doi: 10.1074/jbc.M111.310003. Epub 2012 Mar 16.

33.

5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.

Assaf E, Verlinde-Carvalho M, Delbaldo C, Grenier J, Sellam Z, Pouessel D, Bouaita L, Baumgaertner I, Sobhani I, Tayar C, Paul M, Culine S.

Oncology. 2011;80(5-6):301-6. doi: 10.1159/000329803. Epub 2011 Jul 18.

PMID:
21778770
34.

Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.

Karoui M, Roudot-Thoraval F, Mesli F, Mitry E, Aparicio T, Des Guetz G, Louvet C, Landi B, Tiret E, Sobhani I.

Dis Colon Rectum. 2011 Aug;54(8):930-8. doi: 10.1097/DCR.0b013e31821cced0. Erratum in: Dis Colon Rectum. 2011 Oct;54(10):1338. DesGuetz, Gaetan [corrected to Des Guetz, Gaetan].

PMID:
21730780
35.

Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.

Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I.

Dis Colon Rectum. 2011 Jul;54(7):876-86. doi: 10.1007/DCR.0b013e31820fd2bc.

PMID:
21654256
36.

[HNPCC (hereditary non-polyposis colorectal cancer) or Lynch syndrome: a syndrome related to a failure of DNA repair system].

Manceau G, Karoui M, Charachon A, Delchier JC, Sobhani I.

Bull Cancer. 2011 Mar;98(3):323-36. doi: 10.1684/bdc.2011.1328. Review. French.

37.

Microbial dysbiosis in colorectal cancer (CRC) patients.

Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP.

PLoS One. 2011 Jan 27;6(1):e16393. doi: 10.1371/journal.pone.0016393.

38.

FoxP3 overexpression and CD1a+ and CD3+ depletion in anal tissue as possible mechanisms for increased risk of human papillomavirus-related anal carcinoma in HIV infection.

Yaghoobi M, Le Gouvello S, Aloulou N, Duprez-Dutreuil C, Walker F, Sobhani I.

Colorectal Dis. 2011 Jul;13(7):768-73. doi: 10.1111/j.1463-1318.2010.02283.x. Epub 2010 Apr 10.

PMID:
20394639
39.

Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.

Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E, Tougeron D, Lecomte T, Gornet JM, Sobhani I, Moulin V, Afchain P, Taïeb J, Bonnetain F, Aparicio T.

Ann Oncol. 2010 Sep;21(9):1786-93. doi: 10.1093/annonc/mdq038. Epub 2010 Mar 11.

PMID:
20223786
40.

Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.

Lévy M, Copie-Bergman C, Molinier-Frenkel V, Riou A, Haioun C, Gaulard P, Delfau-Larue MH, Sobhani I, Leroy K, Delchier JC.

Leuk Lymphoma. 2010 Feb;51(2):284-90. doi: 10.3109/10428190903431820.

PMID:
20038225
41.

Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori.

Baumgaertner I, Copie-Bergman C, Levy M, Haioun C, Charachon A, Baia M, Sobhani I, Delchier JC.

World J Gastroenterol. 2009 Dec 7;15(45):5746-50.

42.

Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans.

Sobhani I, Le Gouvello S.

Gut. 2009 Jun;58(6):743-4. doi: 10.1136/gut.2008.175521. No abstract available.

PMID:
19433592
43.

Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients.

Abramowitz L, Mathieu N, Roudot-Thoraval F, Lemarchand N, Bauer P, Hennequin C, Mitry E, Romelaer C, Aparicio T, Sobhani I.

Aliment Pharmacol Ther. 2009 Aug 15;30(4):414-21. doi: 10.1111/j.1365-2036.2009.04026.x. Epub 2009 Apr 17.

44.

Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.

Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D, Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC.

Crit Rev Oncol Hematol. 2009 Sep;71(3):249-57. doi: 10.1016/j.critrevonc.2008.11.006. Epub 2009 Jan 7.

PMID:
19131256
45.

Leptin receptor-related immune response in colorectal tumors: the role of colonocytes and interleukin-8.

Abolhassani M, Aloulou N, Chaumette MT, Aparicio T, Martin-Garcia N, Mansour H, Le Gouvello S, Delchier JC, Sobhani I.

Cancer Res. 2008 Nov 15;68(22):9423-32. doi: 10.1158/0008-5472.CAN-08-1017.

46.

Involvement of the leptin receptor in the immune response in intestinal cancer.

Aloulou N, Bastuji-Garin S, Le Gouvello S, Abolhassani M, Chaumette MT, Charachon A, Leroy K, Sobhani I.

Cancer Res. 2008 Nov 15;68(22):9413-22. doi: 10.1158/0008-5472.CAN-08-0909.

47.

The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.

Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffin B.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):748-55. doi: 10.1097/MEG.0b013e3282f824c9.

PMID:
18617779
48.

Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancers.

El-Bchiri J, Guilloux A, Dartigues P, Loire E, Mercier D, Buhard O, Sobhani I, de la Grange P, Auboeuf D, Praz F, Fléjou JF, Duval A.

PLoS One. 2008 Jul 9;3(7):e2583. doi: 10.1371/journal.pone.0002583.

49.

Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer.

Sobhani I, Tiret E, Lebtahi R, Aparicio T, Itti E, Montravers F, Vaylet C, Rougier P, André T, Gornet JM, Cherqui D, Delbaldo C, Panis Y, Talbot JN, Meignan M, Le Guludec D.

Br J Cancer. 2008 Mar 11;98(5):875-80. doi: 10.1038/sj.bjc.6604263. Epub 2008 Feb 26.

50.

High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.

Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet JP, Sobhani I.

Gut. 2008 Jun;57(6):772-9. Epub 2007 Oct 26.

PMID:
17965063

Supplemental Content

Loading ...
Support Center